169 related articles for article (PubMed ID: 37765090)
1. A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis.
Li KL; Lewis D; Zhu X; Coope DJ; Djoukhadar I; King AT; Cootes T; Jackson A
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765090
[TBL] [Abstract][Full Text] [Related]
2. Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.
Li KL; Djoukhadar I; Zhu X; Zhao S; Lloyd S; McCabe M; McBain C; Evans DG; Jackson A
Neuro Oncol; 2016 Feb; 18(2):275-82. PubMed ID: 26311690
[TBL] [Abstract][Full Text] [Related]
3. The LEGATOS technique: A new tissue-validated dynamic contrast-enhanced MRI method for whole-brain, high-spatial resolution parametric mapping.
Li KL; Lewis D; Coope DJ; Roncaroli F; Agushi E; Pathmanaban ON; King AT; Zhao S; Jackson A; Cootes T; Zhu X
Magn Reson Med; 2021 Oct; 86(4):2122-2136. PubMed ID: 33991126
[TBL] [Abstract][Full Text] [Related]
4. The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.
Lewis D; Donofrio CA; O'Leary C; Li KL; Zhu X; Williams R; Djoukhadar I; Agushi E; Hannan CJ; Stapleton E; Lloyd SK; Freeman SR; Wadeson A; Rutherford SA; Hammerbeck-Ward C; Evans DG; Jackson A; Pathmanaban ON; Roncaroli F; King AT; Coope DJ
J Neurosurg; 2020 May; 134(5):1419-1429. PubMed ID: 32470937
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.
Haldorsen IS; Grüner R; Husby JA; Magnussen IJ; Werner HM; Salvesen OO; Bjørge L; Stefansson I; Akslen LA; Trovik J; Taxt T; Salvesen HB
Eur Radiol; 2013 Oct; 23(10):2916-25. PubMed ID: 23732687
[TBL] [Abstract][Full Text] [Related]
6. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of microvascular permeability of skeletal muscle and texture analysis based on DCE-MRI in alloxan-induced diabetic rabbits.
Liu B; Hu L; Wang L; Xing D; Peng L; Chen P; Zeng F; Liu WV; Liu H; Zha Y
Eur Radiol; 2021 Aug; 31(8):5669-5679. PubMed ID: 33547478
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
10. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
11. Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma.
Mui AWL; Lee AWM; Ng WT; Lee VHF; Vardhanabhuti V; Man SSY; Chua DTT; Guan XY
Phys Imaging Radiat Oncol; 2022 Oct; 24():30-35. PubMed ID: 36148154
[TBL] [Abstract][Full Text] [Related]
12. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
14. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
15. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
16. Human dorsal-root-ganglion perfusion measured in-vivo by MRI.
Godel T; Pham M; Heiland S; Bendszus M; Bäumer P
Neuroimage; 2016 Nov; 141():81-87. PubMed ID: 27423253
[TBL] [Abstract][Full Text] [Related]
17. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
Hectors SJ; Jacobs I; Lok J; Peters J; Bussink J; Hoeben FJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC; Strijkers GJ
Cancer Res; 2018 Mar; 78(6):1561-1570. PubMed ID: 29317433
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
19. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
[TBL] [Abstract][Full Text] [Related]
20. Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer.
Kallehauge JF; Tanderup K; Duan C; Haack S; Pedersen EM; Lindegaard JC; Fokdal LU; Mohamed SM; Nielsen T
Acta Oncol; 2014 Aug; 53(8):1064-72. PubMed ID: 25034348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
